Concentration dependent tautomerism in green [Cu(HL1)(L2)] and brown [Cu(L1)(HL2)] with H2L1 = (E)-N’-(2-hydroxy-3-methoxybenzylidene)- benzoylhydrazone and HL2 = pyridine-4-carboxylic (isonicotinic) acid

The in situ formed hydrazone Schiff base ligand (E)-N’-(2-hydroxy-3-methoxybenzylidene)-benzoylhydrazone (H2L1) reacts with copper(II) acetate in ethanol in the presence of pyridine-4-carboxylic acid (isonicotinic acid, HL2) to green-[Cu(HL1)(L2)]・H2O・C2H5OH (1) and brown-[Cu(L1)(HL2)] (2) complexes which crystallize as concomitant tautomers where either the mono-anion (HL1)- or di-anion (L1)2- of the Schiff base and simultaneously the pyridine-carboxylate (L2)- or the acid (HL2) (both through the pyridine nitrogen atom) function as ligands. The square-planar molecular copper(II) complexes differ in only a localized proton position either on the amide nitrogen of the hydrazone Schiff base in 1 or on the carboxyl group of the isonicotin ligand in 2. The proportion of the tautomeric forms in the crystalline solid-state can be controlled over a wide range from 1:2 = 95 : 5 to ~2 : 98 by increasing the solution concentration. UV/Vis spectral studies show both tautomers to be kinetically stable (inert), that is, with no apparent tautomerization, in acetonitrile solution. The UB3LYP/6-31+G* level optimized structures of the two complexes are in close agreement with experimental findings. The solid-state structures feature 1D hydrogen-bonded chain from charge-assisted O(-) … H–N and O–H … (-)N hydrogen bonding in 1 and 2, respectively. In 1 pyridine-4-carboxylate also assumes a metal-bridging action by coordinating a weakly bound carboxylate group as a fifth ligand to a Cu axial site. Neighboring chains in 1 and 2 are connected by strong π-stacking interactions involving also the five- and six-membered, presumably metalloaromatic Cu-chelate rings

COVID-19 related stigma among the general population in Iran

Funding Information: GT is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration South London at King’s College London NHS Foundation Trust, and by the NIHR Asset Global Health Unit award. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. GT is also supported by the Guy’s and St Thomas’ Charity for the On Trac project (EFT151101), and by the UK Medical Research Council (UKRI) in relation to the Emilia (MR/S001255/1) and Indigo Partnership (MR/R023697/1) awards. Publisher Copyright: © 2022, The Author(s).Peer reviewedPublisher PD